Skip to main content

Failing Fontan Physiology

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Providence Therapeutics
1 program
HeartMate II Ventricular Assist DeviceN/A1 trial
Active Trials
NCT01149603Withdrawn0Est. Sep 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Providence TherapeuticsHeartMate II Ventricular Assist Device

Clinical Trials (1)

NCT01149603Providence TherapeuticsHeartMate II Ventricular Assist Device

The Destination Therapy Evaluation for Failing Fontan Study

Start: Jul 2010Est. completion: Sep 20170
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.